Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Interventions

Cyclophosphamide 139 Vincristine 105 Rituximab 100 Doxorubicin 87 Etoposide 79 Prednisone 69 Cytarabine 67 Filgrastim 63 Specimen Handling 62 Methotrexate 60 Biopsy 60 Magnetic Resonance Spectroscopy 51 fludarabine phosphate 50 Dexamethasone 47 Radiotherapy 43 Peripheral Blood Stem Cell Transplantation 35 Leucovorin 35 Bortezomib 32 Prednisolone 28 Mercaptopurine 27 merphos 24 Ifosfamide 24 Asparaginase 24 Daunorubicin 23 Lenalidomide 22 ibrutinib 21 fludarabine 21 Calcium Dobesilate 21 pegaspargase 19 Alemtuzumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × BNT162 Vaccine × Lymphoid × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡